Hepatocyte growth factor (HGF) has emerged as a potent, endogenous antifibrotic factor that shows an impressive efficacy in ameliorating tissue fibrosis in a wide variety of animal models. Herrero-Fresneda et al. provide new evidence demonstrating that intramuscular injection of HGF gene reduces mortality, inflammation, and renal fibrosis in chronic allograft nephropathy. © 2006 International Society of Nephrology.
CITATION STYLE
Liu, Y., & Yang, J. (2006, July 7). Hepatocyte growth factor: New arsenal in the fights against renal fibrosis? Kidney International. Nature Publishing Group. https://doi.org/10.1038/sj.ki.5001661
Mendeley helps you to discover research relevant for your work.